Article info

Download PDFPDF

Evaluating the endometabolic and bone health effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukaemia: a systematic review protocol

Authors

  1. Correspondence to Dr M Constantine Samaan, Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada; samaanc{at}mcmaster.ca
View Full Text

Citation

Balakumaran J, Birk T, Golemiec B, et al
Evaluating the endometabolic and bone health effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukaemia: a systematic review protocol

Publication history

  • Received February 26, 2019
  • Revised July 31, 2019
  • Accepted August 16, 2019
  • First published September 11, 2019.
Online issue publication 
September 11, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.